# Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous Pemphigoid

> **NCT01571895** · PHASE2 · TERMINATED · sponsor: **Dompé Farmaceutici S.p.A** · enrollment: 4 (actual)

## Conditions studied

- Bullous Pemphigoid

## Interventions

- **DRUG:** DF2156A

## Key facts

- **NCT ID:** NCT01571895
- **Lead sponsor:** Dompé Farmaceutici S.p.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-02-20
- **Primary completion:** 2012-07-05
- **Final completion:** 2012-07-05
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Lack of efficacy observed at 1/3 of the enrollment at investigated dosage. No results available.
- **Last updated:** 2023-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01571895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01571895, "Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous Pemphigoid". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01571895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*